Surging Earnings Estimates Signal Upside for Regeneron (REGN) StockZacks Investment Research • 08/05/26
REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action LawsuitBusiness Wire • 08/05/26
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGNPRNewsWire • 08/04/26
REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for InvestorsPRNewsWire • 08/04/26
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026Newsfile Corp • 08/04/26
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate FailureGlobeNewsWire • 08/04/26
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron's Eylea® 2 mgBusiness Wire • 08/03/26
REGN Class Action Notice: Regeneron Hit with Securities Fraud Lawsuit over Trial Misrepresentations – Investors Urged to Contact BFA Law by September 14 DeadlineGlobeNewsWire • 08/03/26
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPRNewsWire • 07/31/26
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative InnovationGlobeNewsWire • 07/31/26
$REGN Securities: Suffer Losses on Your Regeneron Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover LossesGlobeNewsWire • 07/31/26
Regeneron Q2 Earnings Beat, Sales Up on Dupixent & Eylea HD StrengthZacks Investment Research • 07/30/26
Regeneron (REGN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/30/26
REGN Stockholders Have Rights – If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Recovering Your LossesGlobeNewsWire • 07/30/26
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens BermanPRNewsWire • 07/29/26
REGN Court Deadline: Regeneron Investor Deadline in Securities Fraud Class Action is September 14 – Contact BFA Law if You Lost MoneyGlobeNewsWire • 07/29/26